If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
107.00    0.50 (0.47%)
Bid:
104.00
Ask:
109.00
Spread: 5.00 (4.808%)
Market Cap: £64.07m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Grant of Options

22 Oct 2018 07:00

RNS Number : 6845E
Intercede Group PLC
22 October 2018
 

22 October 2018

Intercede Group plc

 

("Intercede" or the "Company")

 

Grant of Options

 

 

Intercede, the leading specialist in digital identity, credential management and secure mobility, announces that on 19 October 2018 it granted options ("Options") over ordinary shares of 1p in the Company ("Ordinary Shares") under the existing Intercede Group plc Long Term Incentive Plan to Klaas van der Leest, Chief Executive and Andrew Walker, Finance Director.

 

The Options have been granted at a price of 27.0 pence per Ordinary Share, being the closing mid-market price of an Ordinary Share on 18 October 2018. They will be exercisable from 19 October 2021 to 18 October 2028, dependent on the price of an Ordinary Share reaching the following prices for a period of 30 consecutive trading days in the period up to and ending 19 October 2021, being three years from the date of the grant (the "Performance Criteria"):

 

- 69 pence per Ordinary Share ("Tranche 1");

- 119 pence per Ordinary Share ("Tranche 2"); and

- 169 pence per Ordinary Share ("Tranche 3").

Dependent on the Performance Criteria above being achieved, the number of Options that will vest and become exercisable is as follows:

Director

Tranche 1

Tranche 2

Tranche 3

Klaas van der Leest

500,000 Options

250,000 Options

250,000 Options

Andrew Walker

350,000 Options

150,000 Options

150,000 Options

 

Following this grant, there are a total of 2,062,500 Options outstanding, representing approximately 4.1 per cent. of the current issued share capital of the Company.

 

Further detail is set out in the PDMR disclosure tables below.

ENQUIRIES

 

Intercede Group plc

Tel. +44 (0)1455 558111

Klaas van der Leest, Chief Executive

Andrew Walker, Finance Director

finnCap

Tel. + 44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

About Intercede

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Klaas van der Leest

2.

Reason for the Notification

a)

Position/status

Chief Executive

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Intercede Group plc

b)

LEI

213800VFMNCYCDQ65C90

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over Ordinary Shares of 1 pence

Identification code

GB0003287249

b)

Nature of the transactions

Grant of Options over Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

27.0p

1,000,000

d)

Aggregated information:

· Aggregated volumes

· Prices

See 4(c) above

e)

Date of the transaction

19 October 2018

f)

Place of the transaction

Off market transaction

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Walker

2.

Reason for the Notification

a)

Position/status

Finance Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Intercede Group plc

b)

LEI

213800VFMNCYCDQ65C90

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over Ordinary Shares of 1 pence

Identification code

GB0003287249

b)

Nature of the transactions

Grant of Options over Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

27.0p

650,000

d)

Aggregated information:

· Aggregated volumes

· Prices

See 4(c) above

e)

Date of the transaction

19 October 2018

f)

Place of the transaction

Off market transaction

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHVFLFLVBFEFBX
Date   Source Headline
23rd Jun 20267:00 amRNSFinal Results
15th Jun 20267:00 amRNS-RExtension of Partnership with Swissbit
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.